A detailed history of Oppenheimer & CO Inc transactions in Sanofi stock. As of the latest transaction made, Oppenheimer & CO Inc holds 8,317 shares of SNY stock, worth $407,033. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,317
Previous 8,370 0.63%
Holding current value
$407,033
Previous $406,000 17.98%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$48.54 - $58.53 $2,572 - $3,102
-53 Reduced 0.63%
8,317 $479,000
Q2 2024

Aug 07, 2024

SELL
$45.39 - $50.36 $4,085 - $4,532
-90 Reduced 1.06%
8,370 $406,000
Q1 2024

May 06, 2024

SELL
$45.75 - $52.48 $411 - $472
-9 Reduced 0.11%
8,460 $411,000
Q4 2023

Feb 13, 2024

SELL
$43.13 - $54.79 $65,083 - $82,678
-1,509 Reduced 15.12%
8,469 $421,000
Q3 2023

Nov 07, 2023

SELL
$50.95 - $55.2 $20,227 - $21,914
-397 Reduced 3.83%
9,978 $535,000
Q2 2023

Aug 02, 2023

BUY
$50.45 - $57.18 $10,090 - $11,436
200 Added 1.97%
10,375 $559,000
Q1 2023

May 10, 2023

SELL
$45.86 - $54.45 $5,824 - $6,915
-127 Reduced 1.23%
10,175 $553,000
Q4 2022

Feb 07, 2023

BUY
$38.86 - $48.55 $2,059 - $2,573
53 Added 0.52%
10,302 $498,000
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $31,450 - $84,922
-845 Reduced 7.62%
10,249 $390,000
Q2 2022

Aug 08, 2022

BUY
$48.99 - $57.46 $12,149 - $14,250
248 Added 2.29%
11,094 $555,000
Q1 2022

May 12, 2022

BUY
$48.48 - $53.65 $484 - $536
10 Added 0.09%
10,846 $557,000
Q4 2021

Feb 02, 2022

BUY
$47.07 - $52.35 $6,919 - $7,695
147 Added 1.38%
10,836 $543,000
Q3 2021

Nov 12, 2021

BUY
$47.89 - $53.12 $239 - $265
5 Added 0.05%
10,689 $515,000
Q2 2021

Aug 03, 2021

SELL
$49.36 - $54.25 $40,524 - $44,539
-821 Reduced 7.14%
10,684 $563,000
Q1 2021

May 10, 2021

SELL
$45.46 - $50.51 $69,508 - $77,229
-1,529 Reduced 11.73%
11,505 $568,000
Q4 2020

Feb 11, 2021

SELL
$45.3 - $51.62 $832,568 - $948,723
-18,379 Reduced 58.51%
13,034 $634,000
Q3 2020

Nov 13, 2020

SELL
$49.47 - $53.77 $524,530 - $570,123
-10,603 Reduced 25.24%
31,413 $1.58 Million
Q2 2020

Aug 11, 2020

BUY
$42.91 - $52.5 $438,025 - $535,920
10,208 Added 32.09%
42,016 $2.15 Million
Q1 2020

May 08, 2020

SELL
$38.02 - $51.66 $45,319 - $61,578
-1,192 Reduced 3.61%
31,808 $1.39 Million
Q4 2019

Feb 07, 2020

BUY
$44.25 - $50.86 $6,283 - $7,222
142 Added 0.43%
33,000 $1.66 Million
Q3 2019

Oct 31, 2019

BUY
$40.34 - $46.64 $872,876 - $1.01 Million
21,638 Added 192.85%
32,858 $1.52 Million
Q2 2019

Aug 09, 2019

SELL
$40.43 - $44.3 $104,430 - $114,426
-2,583 Reduced 18.71%
11,220 $485,000
Q1 2019

Apr 24, 2019

SELL
$40.83 - $45.43 $42,054 - $46,792
-1,030 Reduced 6.94%
13,803 $611,000
Q4 2018

Jan 29, 2019

SELL
$41.48 - $45.59 $9,084 - $9,984
-219 Reduced 1.45%
14,833 $645,000
Q3 2018

Oct 26, 2018

SELL
$40.0 - $44.84 $11,520 - $12,913
-288 Reduced 1.88%
15,052 $672,000
Q2 2018

Aug 10, 2018

SELL
$37.63 - $41.22 $40,527 - $44,393
-1,077 Reduced 6.56%
15,340 $614,000
Q1 2018

May 01, 2018

SELL
$38.98 - $45.76 $44,593 - $52,349
-1,144 Reduced 6.51%
16,417 $658,000
Q4 2017

Feb 07, 2018

SELL
$42.86 - $50.61 $102,778 - $121,362
-2,398 Reduced 12.01%
17,561 $756,000
Q3 2017

Nov 09, 2017

BUY
$47.04 - $50.34 $938,871 - $1 Million
19,959
19,959 $994,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.